Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer

Table 3 Last disease progression in the previous treatment line in relation to the discontinuation of treatment with FTD/TPI

Last Disease Progression^a	Discontinuation of FTD/TPI Treatment				mCRC Patient Number (In Total)
	Yes		No
	n	%	n	%	n
≤ 7 Days	38	58.72	29	43.28	67
1- < 2 Weeks	25	59.52	17	40.48	42
2- < 3 Weeks	12	52.17	11	47.83	23
3- < 4 Weeks	12	50.0	12	50.00	24
> 4 Weeks	30	47.62	33	52.38	63
					219

ISSN: 1471-2407